Remission induction comparing infliximab and high-dose intravenous steroid, followed by treat-to-target: a double-blind, randomised, controlled trial in new-onset, treatment-naive, rheumatoid arthritis (the IDEA study)

Author(s):
Nam, J.L.; Villeneuve, E.; Hensor, E.M.A.; Conaghan, P.G.; Keen, H.I.; Buch, M.H.; Gough, A.K.; Green, M.J.; Helliwell, P.S.; Keenan, A.M.; Morgan, A.W.; Quinn, M.; Reece, R.; Heijde, D.M. van der; Wakefield, R.J.; Emery, P.
Published
2014
Publication type
Article / Letter to editor
Date issued
2014-01-31
Language
English
Is part of
Annals of the Rheumatic Diseases (2014), Vol. 73, no. 1, p. 75-85
hdl
1887/103667
doi
10.1136/annrheumdis-2013-203440